Overview
Sponsor-declared trial summary
Phase
Human pharmacology (Phase I) - First administration to humans
Status
Ongoing, recruiting
Participants planned
42
Countries
1
Sites
7
Solid Malignancies
Key facts
- Sponsor
- Mestag Therapeutics Limited
- Participant type
- Patients
- Age range
- 18-64 years, 65+ years
- Gender
- Male and Female
- Therapeutic area
- Diseases [C] - Neoplasms [C04]
- Trial duration
- 1 Apr 2026 → ongoing
- Decision date (initial)
- 2026-03-13
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- No
Trial design
CTIS Part I — objectives, methods, condition coding
Conditions and MedDRA coding
Solid Malignancies
| Version | Level | Code | Term | System organ class |
|---|---|---|---|---|
| 21.1 | LLT | 10065252 | Solid tumor | 10029104 |
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
Mestag Therapeutics Limited
- Sponsor organisation
- Mestag Therapeutics Limited
- Address
- Suite 15, Science Village, Chesterford Park, Little Chesterford Science Village Chesterford Park
- City
- Saffron Walden
- Postcode
- CB10 1XL
- Country
- United Kingdom
Scientific contact point
- Organisation
- Mestag Therapeutics Limited
- Contact name
- Colin Lunt
Public contact point
- Organisation
- Mestag Therapeutics Limited
- Contact name
- Colin Lunt
Locations
1 EU/EEA country · 7 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| Spain | Ongoing, recruiting | 42 | 7 |
| Rest of world | — | 0 | — |
Investigational sites
Hospital Universitario Fundacion Jimenez Diaz
Oncología, Avenida De Los Reyes Catolicos 2, 28040, Madrid
Hospital Quironsalud Barcelona
Instituto de Oncología de Barcelona, Placa D'alfonso Comin 5-7, 08023, Barcelona
Hospital Clinico Universitario De Valencia
Oncología Médica, Avenida Blasco Ibanez 17, 46010, Valencia
Hospital Universitari Vall D Hebron
Oncología Médica, Passeig De La Vall D'Hebron 119-129, 08035, Barcelona
Hospital Universitario 12 De Octubre
Oncología Médica, Avenida De Cordoba Sn, 28041, Madrid
Hospital Universitario Hm Sanchinarro
Centro Integral Oncológico Clara Campall (CIOCC) Phase I trials unit, Calle Ona 10, 28050, Madrid
Clinica Universidad De Navarra
Inmunología médica & inmunoterapía, Pio XII Etorbidea 36, 31008, Pamplona
Country notifications
Trial-start, recruitment-start, end and early-termination notifications submitted per Member State
| Country | Trial start | Trial end | Recruitment start | Recruitment end | Early termination |
|---|---|---|---|---|---|
| Spain | 2026-04-01 | 2026-04-09 |
Application history
1 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2026-02-02 | Spain | Acceptable 2026-03-11
|
2026-03-13 |